Resources

The Diabetes Care Project was a 3-year pilot program that analysed new models of health care delivery for adults with type 1 and type 2 diabetes.

Every year, the Australian National Diabetes Audit (ANDA) collects and reports on diabetes-related data from specialist diabetes centres across Australia.

The Australian Government has developed a new national diabetes strategy. This strategy updates and prioritises the response to diabetes for all governments.

The Australian Government has developed a new national diabetes strategy. This strategy updates and prioritises the response to diabetes for all governments.

This plan — Diabetes in Australia: Focus on the Future — outlines ways to implement the Government's Australian National Diabetes Strategy 2016–2020.

Type 2 diabetes is a common chronic disease. Many Australians are at risk of developing type 2 diabetes, especially if they have certain risk factors. This tool uses a brief list of questions to assess the risk of a person developing type 2 diabetes in the next 5 years.

The Australian Government based the Australian National Diabetes Strategy 2016–2020 on the framework provided in this report.

This guideline is particularly for diabetes educators, exercise physiologists or dietitians. It MBS items 81100 to 81125 and can help you substantiate that the requirements for an assessment service or group allied health service for a patient with type 2 diabetes have been met.

This Budget fact sheet outlines how the Government will provide $56 million for research that will give new hope and support to the more than 120,000 Australian children and adults living with type 1 diabetes.

GPs can use this referral form to refer a patient with type 2 diabetes for Medicare rebateable services for allied health group therapy.

This document gives details about how the AUSDRISK tool and scoring system was developed.

This plan guides investments under the Medical Research Future Fund (MRFF) that support new models of care, therapeutics and devices for diabetes and cardiovascular disease.

Suppliers must use this form to make a submission to the Review of CGM products provided through the National Diabetes Services Scheme (NDSS).

This fact sheet answers key questions about the review of Continuous Glucose Monitoring (CGM) products provided through the National Diabetes Services Scheme (NDSS).

This document provides guidance to the CSO Administration Agency, the National Diabetes Services Scheme Administrator and CSO distributors about funding pool and distribution requirements and obligations.

This document covers quality improvement measures for the Practice Incentives Program (PIP).

Stakeholder organisations and other interested parties must use this cover sheet to make a submission to the Review of CGM products provided through the National Diabetes Services Scheme (NDSS).